
Onesource Specialty Pharma Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
- Paid Up Capital ₹ 11.44 Cr
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 450.59 Cr
- Satisfied Charges ₹ 1,250.24 Cr
About Onesource Specialty Pharma
Onesource Specialty Pharma Limited (OSPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 12 June 2007 and has a history of 17 years and eight months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Inbiopro Solutions Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 11.44 Cr.
The company currently has active open charges totaling ₹450.59 Cr. The company has closed loans amounting to ₹1,250.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Onesource Specialty Pharma Limited India are Anurag Bhagania as CFO and Allada Trisha as Company Secretary. Arun Pillai, Gopakumar Nair, Bharat Shah, and Five other members serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
L74140MH2007PLC432497
- Company No.
043095
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2007
- Date of AGM
23 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Onesource Specialty Pharma?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Neeraj Sharma ![]() | Managing Director | 01-Mar-2024 | Current |
Anurag Bhagania ![]() | CFO | 01-Aug-2024 | Current |
Allada Trisha | Company Secretary | 20-Apr-2023 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mahadevan Narayanamoni ![]() | Director | 26-Mar-2021 | Current |
Arun Pillai ![]() | Director | 07-Apr-2021 | Current |
Gopakumar Nair ![]() | Director | 04-May-2023 | Current |
Bharat Shah ![]() | Director | 26-Jul-2024 | Current |
Rajashri Ojha ![]() | Director | 04-May-2023 | Current |
Bhushan Bopardikar ![]() | Director | 14-Aug-2023 | Current |
Financial Performance of Onesource Specialty Pharma.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Onesource Specialty Pharma?
Unlock access to Onesource Specialty Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Related Corporates (Common Directorship)
- Raaj Gprac Private Limited
Rajashri Ojha is a mutual person
- Credila Financial Services Limited
Bharat Shah is a mutual person
- Exide Industries Limited
Bharat Shah is a mutual person
- Rhea Healthcare Private Limited
Bhushan Bopardikar is a mutual person
- Fermenta Biotech Limited
Rajashri Ojha is a mutual person
- Quality Care India Limited
Mahadevan Narayanamoni is a mutual person
Charges (Loans)
₹450.59 Cr
₹1,250.24 Cr
Charges Breakdown by Lending Institutions
- Others : 231.02 Cr
- Idbi Trusteeship Services Limited : 219.57 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
26 Sep 2024 | Others | ₹50.00 Cr | Open |
27 Feb 2024 | Others | ₹150.00 Cr | Open |
25 Jan 2024 | Others | ₹0.20 M | Open |
21 Mar 2022 | Others | ₹20.00 Cr | Open |
13 May 2021 | Idbi Trusteeship Services Limited | ₹200.00 Cr | Open |
How Many Employees Work at Onesource Specialty Pharma?
Unlock and access historical data on people associated with Onesource Specialty Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Onesource Specialty Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onesource Specialty Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.